Healthcare experts have emphasized the need for a comprehensive national strategy to improve access to advanced cancer therapies across India. During a media roundtable titled Bridging Innovation and Affordability in Cancer Care, organized by the Indian Cancer Society during Cancer Survivor Month, oncologists, public health specialists, and cancer survivors discussed the challenges that continue to limit access to modern cancer treatment despite significant scientific progress.
Participants noted that cancer care has undergone major advances over the past decade. New targeted therapies, immunotherapy, precision medicine, and improved diagnostic technologies have significantly enhanced treatment outcomes for many types of cancer. However, these innovations remain beyond the reach of a large number of patients due to financial and infrastructure-related barriers.
Experts pointed out that one of the biggest challenges is the high cost of advanced cancer medicines and treatment procedures. Many patients are unable to afford these therapies, particularly when they require prolonged treatment or specialized medicines that are not widely available in public healthcare facilities.
Another concern highlighted during the discussion was limited insurance coverage for advanced cancer treatments. Although several government and private health insurance schemes provide support for cancer care, experts said that coverage often does not fully meet the cost of newer therapies, leaving patients to bear substantial out-of-pocket expenses.
The panel also stressed the importance of strengthening diagnostic infrastructure across the country. Early diagnosis remains one of the most effective ways to improve survival rates, but access to high-quality diagnostic facilities continues to vary significantly between urban and rural regions. Delays in diagnosis often result in patients seeking treatment at more advanced stages of the disease.
Healthcare professionals further observed that unequal healthcare infrastructure contributes to disparities in cancer care. Major metropolitan cities have access to specialized cancer hospitals, advanced equipment, and trained oncology professionals, while many smaller cities and rural areas continue to face shortages of specialist services and treatment facilities.
Jyotsna Govil, Chairperson of the Indian Cancer Society, said that cancer treatment is entering a new phase driven by scientific innovation. She emphasized that the primary challenge is ensuring that these medical advances become accessible to every eligible patient regardless of geographic location or financial status.
Experts participating in the discussion recommended stronger collaboration between government agencies, healthcare providers, pharmaceutical companies, insurance providers, and patient advocacy organizations. They suggested that coordinated policy measures could help reduce treatment costs, improve reimbursement systems, strengthen diagnostic services, and expand access to quality cancer care nationwide.
They also highlighted the importance of public awareness campaigns promoting early cancer screening and regular health checkups. Increased awareness, combined with timely diagnosis and improved access to treatment, could significantly improve patient outcomes and reduce cancer-related mortality.
The Indian Cancer Society reiterated its commitment to supporting initiatives that improve affordability, patient education, and access to modern cancer care. Experts concluded that scientific breakthroughs can achieve their full public health impact only when healthcare systems ensure that innovative treatments are accessible to all eligible patients across the country.